主管:国家卫生健康委员会
主办:国家卫生健康委医院管理研究所
中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)核心库期刊
《中文核心期刊要目总览》核心期刊

中国护理管理 ›› 2021, Vol. 21 ›› Issue (1): 25-30.doi: 10.3969/j.issn.1672-1756.2021.01.007

• 论 著 • 上一篇    下一篇

肿瘤患者PICC相关上肢无症状静脉血栓的临床调查研究

罗蕾 王国蓉 郭琴 苏畅 李吟枫   

  1. 四川省肿瘤医院·研究所肿瘤内科,电子科技大学医学院,610041 成都市(罗蕾,郭琴,苏畅);护理研究室(王国蓉);护理部(李吟枫)
  • 出版日期:2021-01-15 发布日期:2021-01-15
  • 通讯作者: 王国蓉,博士,主任护师,硕士生导师,护理研究室主任,E-mail:553999838@qq.com
  • 作者简介:罗蕾,硕士,副主任护师,总护士长
  • 基金资助:
    四川省卫生健康委科研项目(130225)

A clinical investigation of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients

LUO Lei, WANG Guorong, GUO Qin, SU Chang, LI Yinfeng   

  1. Department of Internal Medicine, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610041, China
  • Online:2021-01-15 Published:2021-01-15
  • Contact: E-mail:553999838@qq.com

摘要: 目的:分析肿瘤患者PICC相关上肢无症状静脉血栓形成的临床特点,为血栓早期预防提供理论依据。方法:选取2017年4月至2018年10月PICC置管的肿瘤患者127例,在置管前和置管后第2、7、14、21、28、35、42天应用彩色多普勒超声对置管侧上肢静脉的穿刺点、穿刺点上方2?cm处、肘窝上方10?cm处和腋窝4个部位进行随访检测,记录无症状静脉血栓发生时间、部位、血栓分级和统计发生率。多因素分析所采用Logistic回归模型;采用受试者工作特征曲线(ROC)探寻危险临界值。结果:无症状静脉血栓发生率为48.82%,发生无症状血栓中位时间为3天;62例无症状血栓患者共检测出81处静脉血栓,其中深静脉血栓占23.46%,浅静脉血栓占76.54%;血栓分级:Ⅰ级占51.85%,Ⅱ级占37.04%,Ⅲ级占11.11%。美东地区肿瘤协作组评分(OR=9.185,95%CI?4.770~28.262,P<0.001)、静脉血液流速(OR=0.577,95%CI?0.506~0.858,P=0.002)与无症状血栓发生相关。静脉血液流速的危险临界值为4.78cm/s(曲线下面积为0.739,95%CI?0.649~0.830)。结论:肿瘤患者PICC相关上肢无症状血栓发生率高,发生时间早,多发生于穿刺点上方2~10?cm贵要静脉处,以浅静脉血栓为主。建议对活动能力低下,静脉血液流速≤4.78?cm/s的高危人群进行有目的置管前筛查和干预措施,预防无症状静脉血栓的发生。

关键词: 肿瘤患者;PICC;导管相关性静脉血栓;无症状静脉血栓

Abstract: Objective: To investigate the clinical characteristics of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients, and to provide theoretical basis for the early prevention of venous thrombosis. Methods: A total of 127 cancer patients with PICC catheterization from April 2017 to October 2018 were selected. Doppler ultrasound was used to examine the puncture point, 2cm above the puncture point, 10cm above the elbow fossa and armpit of the upper extremity on the side of the catheter. The examinations were before catheterization and on days 2nd, 7th, 14th, 21st, 28th, 35th, and 42nd after catheterization. Results: The incidence of asymptomatic venous thrombosis was 48.82% and the median time of thrombosis was 3 day. A total of 81 thrombosis were detected in 62 patients, of which deep vein thrombosis accounted for 23.46% and superficial vein thrombosis accounted for 76.54%. The rates of thrombus classification (I, II, III) were 51.85%, 37.04%, 11.11% respectively. Logistic regression analysis showed that ECOG (OR=9.185, 95%CI 4.770-28.262, P<0.001), venous flow velocity (OR=0.577, 95%CI 0.506-0.858, P=0.002) were associated with the development of asymptomatic thrombosis. ROC curve analysis of the risk value of venous flow velocity was 4.78 cm/s (AUC is 0.739, 95%CI 0.649-0.830). Conclusion: The incidence of PICC-related asymptomatic thrombosis in cancer patients is high. It mostly occurs 2-10cm above the puncture site. It is suggested that pre-catheterization screening and intervention measures should be conducted in high-risk population with low activity and venous flow rate ≤4.78cm/s to prevent the occurrence of asymptomatic venous thrombosis.

Key words: cancer patients; PICC; catheter-related venous thrombosis; asymptomatic venous thrombosis

中图分类号: 

  • R47